Roozitalab M, Prekete N, Allen M, Grose R, Jones J
Adv Exp Med Biol. 2025; 1464():211-235.
PMID: 39821028
DOI: 10.1007/978-3-031-70875-6_12.
Sardela de Miranda F, Martinez-Marin D, Babcock R, Castro M, Boligala G, Khan S
Front Immunol. 2024; 15:1498942.
PMID: 39703517
PMC: 11657241.
DOI: 10.3389/fimmu.2024.1498942.
Liu Y, Xiao H, Zeng H, Xiang Y
Int J Oncol. 2024; 65(6).
PMID: 39513610
PMC: 11575928.
DOI: 10.3892/ijo.2024.5705.
Shen Q, Murakami K, Sotov V, Butler M, Ohashi P, Reedijk M
Sci Adv. 2024; 10(44):eado8275.
PMID: 39475614
PMC: 11524187.
DOI: 10.1126/sciadv.ado8275.
Ghebremedhin A, Athavale D, Zhang Y, Yao X, Balch C, Song S
Cancers (Basel). 2024; 16(19).
PMID: 39410029
PMC: 11475569.
DOI: 10.3390/cancers16193410.
The Mutational and Microenvironmental Landscape of Cutaneous Squamous Cell Carcinoma: A Review.
Hosseini T, Park S, Guo T
Cancers (Basel). 2024; 16(16).
PMID: 39199674
PMC: 11352924.
DOI: 10.3390/cancers16162904.
Tumor associated macrophages in breast cancer progression: implications and clinical relevance.
Stavrou M, Constantinidou A
Front Immunol. 2024; 15:1441820.
PMID: 39044824
PMC: 11263030.
DOI: 10.3389/fimmu.2024.1441820.
Detailed Profiling of the Tumor Microenvironment in Ethnic Breast Cancer, Using Tissue Microarrays and Multiplex Immunofluorescence.
Zaakouk M, Longworth A, Hunter K, Jiman S, Kearns D, El-Deftar M
Int J Mol Sci. 2024; 25(12).
PMID: 38928207
PMC: 11203983.
DOI: 10.3390/ijms25126501.
Milestones in tumor vascularization and its therapeutic targeting.
de Palma M, Hanahan D
Nat Cancer. 2024; 5(6):827-843.
PMID: 38918437
DOI: 10.1038/s43018-024-00780-7.
Prognostic Significance of CD163+ and/or CD206+ Tumor-Associated Macrophages Is Linked to Their Spatial Distribution and Tumor-Infiltrating Lymphocytes in Breast Cancer.
Fang C, Cheung M, Chan R, Poon I, Lee C, To C
Cancers (Basel). 2024; 16(11).
PMID: 38893266
PMC: 11172176.
DOI: 10.3390/cancers16112147.
Roles of reactive oxygen species in inflammation and cancer.
Yu Y, Liu S, Yang L, Song P, Liu Z, Liu X
MedComm (2020). 2024; 5(4):e519.
PMID: 38576456
PMC: 10993368.
DOI: 10.1002/mco2.519.
Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma.
Sitaram R, Ljungberg B
Ups J Med Sci. 2024; 129.
PMID: 38571885
PMC: 10989218.
DOI: 10.48101/ujms.v129.9407.
Immune cell networking in solid tumors: focus on macrophages and neutrophils.
Di Ceglie I, Carnevale S, Rigatelli A, Grieco G, Molisso P, Jaillon S
Front Immunol. 2024; 15:1341390.
PMID: 38426089
PMC: 10903099.
DOI: 10.3389/fimmu.2024.1341390.
Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis.
Mierke C
Biomolecules. 2024; 14(2).
PMID: 38397421
PMC: 10887446.
DOI: 10.3390/biom14020184.
Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities.
Dominguez-Cejudo M, Gil-Torralvo A, Cejuela M, Molina-Pinelo S, Salvador Bofill J
Int J Mol Sci. 2023; 24(23).
PMID: 38069096
PMC: 10706312.
DOI: 10.3390/ijms242316771.
Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis.
Baritaki S, Zaravinos A
Cancers (Basel). 2023; 15(20).
PMID: 37894300
PMC: 10605344.
DOI: 10.3390/cancers15204932.
The significance of immune microenvironment in patients with endometriosis.
Pavaleanu I, Balan R, Grigoras A, Balan T, Amalinei C
Rom J Morphol Embryol. 2023; 64(3):343-354.
PMID: 37867352
PMC: 10720939.
DOI: 10.47162/RJME.64.3.06.
Challenges and Opportunities Modeling the Dynamic Tumor Matrisome.
Peyton S, Platt M, Cukierman E
BME Front. 2023; 4:0006.
PMID: 37849664
PMC: 10521682.
DOI: 10.34133/bmef.0006.
Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature.
Wu Y, Shang J, Ruan Q, Tan X
Sci Rep. 2023; 13(1):17577.
PMID: 37845218
PMC: 10579418.
DOI: 10.1038/s41598-023-43036-7.
Influence of Macrophages on Vascular Invasion of Inflammatory Breast Cancer Emboli Measured Using an In Vitro Microfluidic Multi-Cellular Platform.
Gadde M, Mehrabi-Dehdezi M, Debeb B, Woodward W, Rylander M
Cancers (Basel). 2023; 15(19).
PMID: 37835577
PMC: 10571588.
DOI: 10.3390/cancers15194883.